Health Condition 1: null- Androgenetic Alopecia
Conditions
Interventions
Intervention1: Autologous Human Platelet Lysate (HPL): 3 doses of HPL will be injected intradermally at an interval of one month each.
Control Intervention1: Standard Therapy: Topical treatments as d
Sponsors
Kasiak Research Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male subjects, aged between 18 to 50 years (both inclusive) and in general good health 2. Subjects willing to refrain from other AGA treatments during the entire study duration 3. Subjects who are willing to give informed consent and adhere to the study protocol.
Exclusion criteria
Exclusion criteria: 1. Subjects aged 50 years 2. Subjects with dermatological disorder of scalp that might interfere with study evaluation 3. Subjects on Anti-coagulant therapy 4. Subjects with clinically significant medical or psychiatric disease as determined by the investigator. 5. Subjects with dermatological disorder of scalp that might interfere with study evaluation 6. Subjects unwilling to or unable to comply with the study protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Improvement in Calibre & Density of Hair as assessed by Folliscope 2. Photographic assessment from randomization to end of study Timepoint: End of Study- 6 Months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Physicianâ??s assessment score 2. Patientâ??s self assessment score Timepoint: End of Study- 6 Months | — |
Countries
India
Contacts
Public ContactDr Kaushal Shah
Outcome results
None listed